Literature DB >> 16873548

Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1).

Jiabin Tang1, Raymond L Erikson, Xiaoqi Liu.   

Abstract

Although the essential function of checkpoint kinase 1 (Chk1) in DNA damage response has been well established, the role of Chk1 in normal cell cycle progression is unclear. By using RNAi to specifically deplete Chk1, we determined loss-of-function phenotypes in HeLa cells. A vector-based RNAi approach showed that Chk1 is required for normal cell proliferation and survival, inasmuch as a dramatic cell-cycle arrest at G(2)/M phase and massive apoptosis were observed in Chk1-deficient cells. Coupling of siRNA with cell synchronization further revealed that Chk1 depletion leads to metaphase block, as indicated by various mitotic markers. Neither bipolar spindle formation nor centrosome functions were affected by Chk1 depletion; however, the depleted cells exhibited chromosome misalignment during metaphase, chromosome lagging during anaphase, and kinetochore defects within the regions of misaligned/lagging chromosomes. Moreover, we showed that Chk1 is a negative regulator of polo-like kinase 1 (Plk1), in either the absence or presence of DNA damage. Finally, Chk1 depletion leads to the activation of the spindle checkpoint because codepletion of spindle checkpoint proteins rescues the Chk1 depletion-induced mitotic arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873548      PMCID: PMC1567681          DOI: 10.1073/pnas.0604987103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

2.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

3.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

Authors:  H Takai; K Tominaga; N Motoyama; Y A Minamishima; H Nagahama; T Tsukiyama; K Ikeda; K Nakayama; M Nakanishi; K Nakayama
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

4.  Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion.

Authors:  M A van Vugt; V A Smits; R Klompmaker; R H Medema
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

5.  Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.

Authors:  Mei-Shya Chen; Christine E Ryan; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

6.  Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

Authors:  Michael H Lam; Qinghua Liu; Stephen J Elledge; Jeffrey M Rosen
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

7.  Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects.

Authors:  George Zachos; Michael D Rainey; David A F Gillespie
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

8.  Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint.

Authors:  Zehan Chen; Zhan Xiao; Jun Chen; Shi-Chung Ng; Thomas Sowin; Hing Sham; Saul Rosenberg; Steve Fesik; Haiying Zhang
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

9.  Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.

Authors:  Hui Zhao; Janis L Watkins; Helen Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-24       Impact factor: 11.205

Review 10.  Wee1-dependent mechanisms required for coordination of cell growth and cell division.

Authors:  Douglas R Kellogg
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

View more
  55 in total

1.  Chk1 is required for spindle checkpoint function.

Authors:  George Zachos; Elizabeth J Black; Mark Walker; Mary T Scott; Paola Vagnarelli; William C Earnshaw; David A F Gillespie
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

2.  The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression.

Authors:  Sirisha Peddibhotla; Zhubo Wei; Rao Papineni; Micheal H Lam; Jeffrey M Rosen; Pumin Zhang
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

3.  VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

Authors:  Sandrine Passemard; Vincent El Ghouzzi; Hala Nasser; Catherine Verney; Guilan Vodjdani; Adrien Lacaud; Sophie Lebon; Marc Laburthe; Patrick Robberecht; Jeannette Nardelli; Shyamala Mani; Alain Verloes; Pierre Gressens; Vincent Lelièvre
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

Review 4.  Mitotic crisis: the unmasking of a novel role for RPA.

Authors:  Rachel William Anantha; James A Borowiec
Journal:  Cell Cycle       Date:  2009-02-21       Impact factor: 4.534

5.  The spindle assembly checkpoint: More than just keeping track of the spindle.

Authors:  Katherine S Lawrence; JoAnne Engebrecht
Journal:  Trends Cell Mol Biol       Date:  2015

6.  A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.

Authors:  Neil Warner; Aaron Burberry; Luigi Franchi; Yun-Gi Kim; Christine McDonald; Maureen A Sartor; Gabriel Núñez
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

7.  Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1.

Authors:  Yu-Che Cheng; Tsong-Yu Lin; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

8.  LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models.

Authors:  Darlene Barnard; H Bruce Diaz; Teresa Burke; Gregory Donoho; Richard Beckmann; Bonita Jones; David Barda; Constance King; Mark Marshall
Journal:  Invest New Drugs       Date:  2015-11-27       Impact factor: 3.850

Review 9.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

10.  Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

Authors:  David O Azorsa; Irma M Gonzales; Gargi D Basu; Ashish Choudhary; Shilpi Arora; Kristen M Bisanz; Jeffrey A Kiefer; Meredith C Henderson; Jeffrey M Trent; Daniel D Von Hoff; Spyro Mousses
Journal:  J Transl Med       Date:  2009-06-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.